PCa patients whose cancer was recurring after treatment had significantly higher GAD-10 total scores (M = 16.57, SD = 5.31) than men whose PCa was in remission (M = 13.44, SD = 4.06), F(1,253) = 15.655, p < 0.001, partial eta squared = 0.058. Here, GAD1 is linked to posterior cortical atrophy.